| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteogenesis Imperfecta | 5 | 2024 | 167 | 2.960 |
Why?
|
| Osteoblasts | 3 | 2024 | 160 | 1.230 |
Why?
|
| Intellectual Disability | 6 | 2025 | 1048 | 1.170 |
Why?
|
| SOX9 Transcription Factor | 1 | 2024 | 86 | 0.810 |
Why?
|
| MAP Kinase Signaling System | 2 | 2024 | 302 | 0.800 |
Why?
|
| Developmental Disabilities | 4 | 2025 | 718 | 0.790 |
Why?
|
| Osteogenesis | 4 | 2024 | 162 | 0.790 |
Why?
|
| Coat Protein Complex I | 1 | 2021 | 14 | 0.710 |
Why?
|
| Coatomer Protein | 1 | 2021 | 30 | 0.710 |
Why?
|
| Hand Deformities, Congenital | 2 | 2021 | 95 | 0.670 |
Why?
|
| Cell Differentiation | 4 | 2024 | 1842 | 0.660 |
Why?
|
| Citrullinemia | 1 | 2020 | 15 | 0.650 |
Why?
|
| Osteoporosis | 1 | 2021 | 132 | 0.650 |
Why?
|
| Actins | 3 | 2021 | 311 | 0.640 |
Why?
|
| Bone and Bones | 1 | 2021 | 294 | 0.600 |
Why?
|
| Endocrinology | 1 | 2020 | 128 | 0.570 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2021 | 205 | 0.510 |
Why?
|
| DNA-Binding Proteins | 4 | 2023 | 1877 | 0.500 |
Why?
|
| Bone Resorption | 1 | 2016 | 50 | 0.500 |
Why?
|
| Mutation, Missense | 2 | 2018 | 891 | 0.490 |
Why?
|
| Mutation | 10 | 2025 | 5941 | 0.460 |
Why?
|
| Stromal Cells | 3 | 2006 | 301 | 0.450 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 4429 | 0.450 |
Why?
|
| Mediator Complex | 2 | 2025 | 55 | 0.380 |
Why?
|
| Mice | 10 | 2024 | 17596 | 0.360 |
Why?
|
| Animals | 15 | 2024 | 33051 | 0.360 |
Why?
|
| Artificial Intelligence | 2 | 2025 | 300 | 0.320 |
Why?
|
| Mice, Transgenic | 3 | 2024 | 2310 | 0.310 |
Why?
|
| Micrognathism | 2 | 2021 | 65 | 0.300 |
Why?
|
| Abnormalities, Multiple | 3 | 2025 | 964 | 0.300 |
Why?
|
| Trans-Activators | 2 | 2015 | 675 | 0.280 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 808 | 0.280 |
Why?
|
| Urethra | 2 | 2025 | 83 | 0.280 |
Why?
|
| Arginine | 2 | 2020 | 335 | 0.270 |
Why?
|
| Humans | 34 | 2025 | 126753 | 0.260 |
Why?
|
| Fractures, Bone | 2 | 2020 | 191 | 0.260 |
Why?
|
| Bone Marrow Cells | 3 | 2005 | 238 | 0.250 |
Why?
|
| Posthumous Conception | 1 | 2025 | 4 | 0.240 |
Why?
|
| Sperm Retrieval | 1 | 2025 | 12 | 0.240 |
Why?
|
| Semen Preservation | 1 | 2025 | 14 | 0.240 |
Why?
|
| Whole Genome Sequencing | 4 | 2024 | 319 | 0.230 |
Why?
|
| Lasers, Solid-State | 1 | 2025 | 18 | 0.230 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2025 | 31 | 0.230 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 63 | 0.220 |
Why?
|
| Chromosome Inversion | 1 | 2024 | 73 | 0.220 |
Why?
|
| Amino Acid Transport System y+L | 2 | 2023 | 17 | 0.220 |
Why?
|
| Prostatic Hyperplasia | 1 | 2025 | 114 | 0.220 |
Why?
|
| Membrane Proteins | 3 | 2024 | 1569 | 0.210 |
Why?
|
| Spermatozoa | 1 | 2025 | 238 | 0.210 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2024 | 136 | 0.210 |
Why?
|
| NIH 3T3 Cells | 1 | 2023 | 92 | 0.210 |
Why?
|
| Prostatectomy | 1 | 2025 | 309 | 0.210 |
Why?
|
| Gene Knock-In Techniques | 1 | 2024 | 119 | 0.200 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2023 | 19 | 0.200 |
Why?
|
| Male | 18 | 2025 | 62543 | 0.200 |
Why?
|
| DNA Helicases | 3 | 2017 | 229 | 0.200 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 2 | 2023 | 113 | 0.200 |
Why?
|
| Glycine | 1 | 2024 | 161 | 0.200 |
Why?
|
| Water | 1 | 2024 | 186 | 0.200 |
Why?
|
| Endoscopy | 1 | 2025 | 280 | 0.200 |
Why?
|
| Heterozygote | 3 | 2025 | 690 | 0.190 |
Why?
|
| Laser Therapy | 1 | 2025 | 229 | 0.190 |
Why?
|
| Stem Cells | 2 | 2024 | 683 | 0.190 |
Why?
|
| Receptors, Glycine | 1 | 2022 | 16 | 0.190 |
Why?
|
| Caenorhabditis elegans | 1 | 2023 | 228 | 0.190 |
Why?
|
| Child | 10 | 2025 | 25101 | 0.180 |
Why?
|
| Exome | 4 | 2021 | 1064 | 0.180 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 316 | 0.180 |
Why?
|
| Down-Regulation | 1 | 2023 | 646 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2022 | 3262 | 0.180 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 70 | 0.180 |
Why?
|
| Aniridia | 1 | 2021 | 11 | 0.180 |
Why?
|
| Golgi Apparatus | 1 | 2021 | 90 | 0.170 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 415 | 0.170 |
Why?
|
| Collagen Type I | 1 | 2021 | 113 | 0.170 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2021 | 33 | 0.170 |
Why?
|
| Embryo, Nonmammalian | 1 | 2021 | 137 | 0.170 |
Why?
|
| Transition to Adult Care | 1 | 2023 | 122 | 0.170 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2021 | 968 | 0.170 |
Why?
|
| Carrier Proteins | 2 | 2023 | 1011 | 0.170 |
Why?
|
| Cerebellar Ataxia | 1 | 2021 | 69 | 0.170 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 202 | 0.160 |
Why?
|
| Transcription Factors | 5 | 2023 | 2337 | 0.160 |
Why?
|
| Introns | 1 | 2021 | 281 | 0.160 |
Why?
|
| Ammonia | 1 | 2020 | 70 | 0.160 |
Why?
|
| Genome, Human | 2 | 2024 | 1279 | 0.160 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2019 | 30 | 0.160 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 265 | 0.160 |
Why?
|
| Hypothermia | 1 | 2020 | 63 | 0.160 |
Why?
|
| Diphosphonates | 1 | 2019 | 41 | 0.160 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2020 | 42 | 0.160 |
Why?
|
| Proteomics | 1 | 2023 | 562 | 0.160 |
Why?
|
| Phenotype | 7 | 2025 | 4304 | 0.150 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2024 | 508 | 0.150 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 658 | 0.150 |
Why?
|
| Autism Spectrum Disorder | 2 | 2022 | 423 | 0.150 |
Why?
|
| Diet, Protein-Restricted | 1 | 2020 | 82 | 0.150 |
Why?
|
| Carboxypeptidases | 1 | 2018 | 17 | 0.150 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2022 | 526 | 0.150 |
Why?
|
| Zebrafish | 1 | 2021 | 402 | 0.150 |
Why?
|
| Female | 14 | 2025 | 68330 | 0.150 |
Why?
|
| Exons | 2 | 2020 | 757 | 0.150 |
Why?
|
| Protein Binding | 2 | 2017 | 1661 | 0.150 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2018 | 63 | 0.150 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2018 | 13 | 0.140 |
Why?
|
| Infant, Newborn | 7 | 2020 | 8347 | 0.140 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 398 | 0.140 |
Why?
|
| Peripheral Nerves | 1 | 2018 | 81 | 0.140 |
Why?
|
| Autistic Disorder | 1 | 2022 | 363 | 0.140 |
Why?
|
| Cell Survival | 3 | 2025 | 841 | 0.140 |
Why?
|
| Multiple Carboxylase Deficiency | 1 | 2018 | 3 | 0.140 |
Why?
|
| Neonatal Screening | 2 | 2017 | 190 | 0.140 |
Why?
|
| Signal Transduction | 2 | 2023 | 4472 | 0.140 |
Why?
|
| Motor Neurons | 1 | 2018 | 122 | 0.140 |
Why?
|
| Spine | 1 | 2018 | 137 | 0.140 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2018 | 27 | 0.140 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2017 | 5 | 0.140 |
Why?
|
| Drosophila | 1 | 2022 | 767 | 0.130 |
Why?
|
| Fibroblasts | 1 | 2021 | 819 | 0.130 |
Why?
|
| Homocystinuria | 1 | 2017 | 26 | 0.130 |
Why?
|
| Purkinje Cells | 1 | 2018 | 156 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 380 | 0.130 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2017 | 44 | 0.130 |
Why?
|
| Child, Preschool | 7 | 2021 | 14347 | 0.130 |
Why?
|
| Cell Transplantation | 1 | 2016 | 35 | 0.130 |
Why?
|
| Anabolic Agents | 1 | 2016 | 15 | 0.130 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 109 | 0.130 |
Why?
|
| Biological Therapy | 1 | 2016 | 25 | 0.130 |
Why?
|
| Brain | 2 | 2021 | 3038 | 0.120 |
Why?
|
| Drug Therapy | 1 | 2016 | 83 | 0.120 |
Why?
|
| Soluble Guanylyl Cyclase | 1 | 2016 | 7 | 0.120 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 191 | 0.120 |
Why?
|
| Lung | 1 | 2024 | 1516 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 576 | 0.120 |
Why?
|
| Face | 1 | 2017 | 193 | 0.120 |
Why?
|
| DNA, Ribosomal | 1 | 2015 | 52 | 0.120 |
Why?
|
| Moyamoya Disease | 1 | 2016 | 41 | 0.120 |
Why?
|
| Esophageal Achalasia | 1 | 2016 | 44 | 0.120 |
Why?
|
| Cerebellum | 1 | 2018 | 414 | 0.110 |
Why?
|
| Seizures | 1 | 2020 | 847 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1861 | 0.110 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2016 | 174 | 0.110 |
Why?
|
| Muscle Proteins | 1 | 2017 | 398 | 0.110 |
Why?
|
| Echoencephalography | 1 | 2014 | 26 | 0.110 |
Why?
|
| Kidney | 1 | 2020 | 1283 | 0.100 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2017 | 459 | 0.100 |
Why?
|
| Genetic Testing | 2 | 2018 | 1056 | 0.100 |
Why?
|
| Disease Management | 1 | 2017 | 541 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 2975 | 0.100 |
Why?
|
| Albuterol | 1 | 2013 | 52 | 0.100 |
Why?
|
| Nitric Oxide | 1 | 2016 | 461 | 0.100 |
Why?
|
| Proteoglycans | 2 | 2005 | 79 | 0.100 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2013 | 51 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 2025 | 3066 | 0.100 |
Why?
|
| Drug Overdose | 1 | 2013 | 71 | 0.090 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 1004 | 0.090 |
Why?
|
| Genetic Therapy | 1 | 2016 | 683 | 0.090 |
Why?
|
| White Matter | 1 | 2014 | 205 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 1204 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2017 | 1508 | 0.080 |
Why?
|
| Adolescent | 6 | 2019 | 20002 | 0.080 |
Why?
|
| Young Adult | 5 | 2025 | 9665 | 0.080 |
Why?
|
| Retrospective Studies | 6 | 2025 | 17005 | 0.070 |
Why?
|
| Infant, Premature | 1 | 2014 | 826 | 0.070 |
Why?
|
| DNA Mutational Analysis | 2 | 2021 | 781 | 0.070 |
Why?
|
| Biglycan | 2 | 2005 | 6 | 0.070 |
Why?
|
| Hypertension | 1 | 2016 | 1301 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 3695 | 0.070 |
Why?
|
| Antigens, Surface | 2 | 2005 | 114 | 0.070 |
Why?
|
| Amino Acids | 2 | 2020 | 615 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2005 | 152 | 0.060 |
Why?
|
| Infant | 6 | 2018 | 12771 | 0.060 |
Why?
|
| Adult | 7 | 2025 | 30410 | 0.060 |
Why?
|
| Refrigeration | 1 | 2025 | 10 | 0.060 |
Why?
|
| Semen Analysis | 1 | 2025 | 35 | 0.060 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2006 | 105 | 0.060 |
Why?
|
| Cryopreservation | 1 | 2025 | 74 | 0.060 |
Why?
|
| Steroids | 1 | 2006 | 157 | 0.060 |
Why?
|
| Integrin-Binding Sialoprotein | 1 | 2005 | 2 | 0.060 |
Why?
|
| Bone Matrix | 1 | 2005 | 7 | 0.060 |
Why?
|
| Sialoglycoproteins | 1 | 2005 | 42 | 0.060 |
Why?
|
| Mucous Membrane | 1 | 2025 | 86 | 0.060 |
Why?
|
| Osteocalcin | 1 | 2005 | 45 | 0.060 |
Why?
|
| Alkaline Phosphatase | 1 | 2005 | 92 | 0.060 |
Why?
|
| Osteopontin | 1 | 2005 | 51 | 0.060 |
Why?
|
| Alleles | 2 | 2021 | 1609 | 0.060 |
Why?
|
| Pan troglodytes | 1 | 2024 | 74 | 0.050 |
Why?
|
| Hyaluronan Receptors | 2 | 2002 | 64 | 0.050 |
Why?
|
| HMGB1 Protein | 1 | 2024 | 25 | 0.050 |
Why?
|
| Therapeutic Irrigation | 1 | 2024 | 42 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2023 | 3709 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2005 | 299 | 0.050 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2024 | 69 | 0.050 |
Why?
|
| Mosaicism | 1 | 2025 | 230 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2018 | 4954 | 0.050 |
Why?
|
| Biological Variation, Population | 1 | 2023 | 26 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 2304 | 0.050 |
Why?
|
| Cystectomy | 1 | 2024 | 158 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2006 | 2893 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2005 | 240 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 1597 | 0.050 |
Why?
|
| Genotype | 2 | 2019 | 2595 | 0.050 |
Why?
|
| Growth Disorders | 1 | 2023 | 183 | 0.050 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2023 | 155 | 0.040 |
Why?
|
| Facies | 1 | 2021 | 156 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2021 | 108 | 0.040 |
Why?
|
| DNA | 1 | 2006 | 1419 | 0.040 |
Why?
|
| Rats | 1 | 2006 | 3390 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 96 | 0.040 |
Why?
|
| Cell Line | 1 | 2005 | 2560 | 0.040 |
Why?
|
| Machine Learning | 1 | 2023 | 325 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 2225 | 0.040 |
Why?
|
| Serine-Type D-Ala-D-Ala Carboxypeptidase | 1 | 2018 | 4 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2019 | 167 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2019 | 247 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2019 | 190 | 0.040 |
Why?
|
| Health Personnel | 1 | 2023 | 533 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 2018 | 160 | 0.030 |
Why?
|
| Osteosarcoma | 1 | 2001 | 259 | 0.030 |
Why?
|
| Middle Aged | 3 | 2025 | 27697 | 0.030 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2018 | 63 | 0.030 |
Why?
|
| Hydroxocobalamin | 1 | 2017 | 9 | 0.030 |
Why?
|
| Carnitine | 1 | 2018 | 68 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 1234 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2019 | 510 | 0.030 |
Why?
|
| Colon | 1 | 2019 | 353 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 348 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 3498 | 0.030 |
Why?
|
| Algorithms | 1 | 2023 | 1633 | 0.030 |
Why?
|
| Sf9 Cells | 1 | 2016 | 10 | 0.030 |
Why?
|
| Aged | 2 | 2025 | 20344 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2001 | 428 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2016 | 55 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2016 | 187 | 0.030 |
Why?
|
| Pol1 Transcription Initiation Complex Proteins | 1 | 2015 | 5 | 0.030 |
Why?
|
| Genes, rRNA | 1 | 2015 | 18 | 0.030 |
Why?
|
| RNA Polymerase I | 1 | 2015 | 11 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2016 | 264 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 269 | 0.030 |
Why?
|
| Time Factors | 1 | 2025 | 6134 | 0.030 |
Why?
|
| Cell Nucleolus | 1 | 2015 | 47 | 0.030 |
Why?
|
| Homozygote | 1 | 2017 | 540 | 0.030 |
Why?
|
| COS Cells | 1 | 2015 | 244 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2016 | 369 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2016 | 599 | 0.030 |
Why?
|
| Peptides | 1 | 2018 | 829 | 0.030 |
Why?
|
| Ribosomes | 1 | 2015 | 123 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 578 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 538 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 759 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2025 | 6214 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2023 | 4504 | 0.030 |
Why?
|
| Behavior | 1 | 2014 | 69 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2015 | 321 | 0.030 |
Why?
|
| Pedigree | 1 | 2017 | 1656 | 0.030 |
Why?
|
| Hypokalemia | 1 | 2013 | 40 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 3907 | 0.020 |
Why?
|
| Chromatin | 1 | 2015 | 472 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2002 | 49 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2013 | 225 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2013 | 669 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 5114 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 3222 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2018 | 1853 | 0.020 |
Why?
|
| Integrin alphaV | 1 | 2002 | 3 | 0.010 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2002 | 18 | 0.010 |
Why?
|
| L-Selectin | 1 | 2002 | 19 | 0.010 |
Why?
|
| Integrin beta3 | 1 | 2002 | 27 | 0.010 |
Why?
|
| S Phase | 1 | 2002 | 71 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 2002 | 99 | 0.010 |
Why?
|
| G1 Phase | 1 | 2002 | 65 | 0.010 |
Why?
|
| P-Selectin | 1 | 2002 | 68 | 0.010 |
Why?
|
| Bone Remodeling | 1 | 2002 | 55 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 307 | 0.010 |
Why?
|
| United States | 1 | 2016 | 11310 | 0.010 |
Why?
|
| Osteoma, Osteoid | 1 | 2001 | 5 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 307 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 720 | 0.010 |
Why?
|
| Mitosis | 1 | 2001 | 190 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2002 | 754 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2001 | 223 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 985 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2001 | 2537 | 0.010 |
Why?
|